Tissue Engineering & 3D Bioprinting represents a revolutionary convergence of biomaterials, cellular biology, and digital fabrication technologies aimed at constructing functional tissues for therapeutic and research applications. Using bioinks composed of living cells and supportive matrices, scientists are now printing complex, multi-layered structures that mimic natural tissue architecture. This technique enables patient-specific constructs for skin, bone, cartilage, and even organ precursors. Tissue Engineering & 3D Bioprinting also supports advancements in disease modeling and drug screening by producing physiologically relevant tissue analogs. Innovations in scaffold design, vascularization, and bioprinter resolution continue to overcome previous limitations, moving the field closer to fully implantable and vascularized organs. Its implications span regenerative medicine, personalized implants, and fundamental biological research.
Title : Improving health in over 40,000 patients: The impact of nanomedicine fighting antibiotic resistant infections
Thomas J Webster, Brown University, United States
Title : Renewed novel biotech ideas, with bioreactor bioengineering economic impact
Murray Moo Young, University of Waterloo, Canada
Title : Osmotic lysis–driven Extracellular Vesicle (EV) engineering
Limongi Tania, University of Turin, Italy
Title : Why do 90% of the drugs fail in development? An analysis of 82+ submissions; and a case study of immunotherapy
Narendra Chirmule, Indian Institute of Technology (IIT), India
Title : Predicting wound closure and future segmentation masks in wound healing assays
Alfredo De Cillis, Univeristy of Salento, CNR Nanotec, Italy
Title : Scientist’s computational lawyer
Julia Sidorova, Instituto Carlos III de Salud (CIBER-EHD), Spain